HCRT and COVID-19: This observational study analysed plasma orexin A, substance P, bradykinin, and des-Arg9-bradykinin (DABK) in 78 ICU COVID-19 patients, 14 survivors of severe COVID-19 (2.5-yr follow-ups), and 14 healthy controls.